Signaling Pathways - Vascular Disrupting Agents (VDA) - Sphingosine kinases (SphKs) - HCV Proteases - HER2
清除全部
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B2298 Plinabulin (NPI-2358)中文名: 普那布林Target: Vascular Disrupting Agents (VDA)Summary: 血管破坏剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8528 TAK-285Target: EGFR|HER2Summary: HER2/EGFR(HER1)抑制剂
- A8366 ARRY-380Target: HER2Summary: 酪氨酸激酶HER2和P95-HER2抑制剂。
- A5618 Daclatasvir (BMS-790052)中文名: 达卡他韦Target: HCV ProteasesSummary: HCV NS5A抑制剂
- A3820 Simeprevir1 Citation中文名: 西咪匹韦Target: HCV ProteasesSummary: HCV NS3/4A蛋白酶抑制剂
- A3717 PF-5431 CitationTarget: Sphingosine kinases (SphKs)Summary: SphK1选择性抑制剂
- A3145 Afatinib dimaleate中文名: 马来酸阿法替尼Target: EGFR|HER2Summary: EGFR抑制剂
- A4024 Danoprevir (RG7227)中文名: 丹诺瑞韦Target: HCV ProteasesSummary: HCV NS3/4A蛋白酶抑制剂